Insulin and the Regulation of the Cardiovascular System: Role of the l-arginine Nitric Oxide Pathway and the Sympathetic Nervous System

  • U. Scherrer


The past several years have witnessed a major surge of interest in the cardiovascular actions of insulin and the potential role played by both the sympathetic nervous system and the l-arginine nitric oxide system in the mediation of these actions.


Insulin Infusion Sympathetic Nerve Activity Muscle Sympathetic Nerve Activity Plasma Insulin Concentration Muscle Blood Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abramson DI, Schkloven N, Margolis MN, Mirsky IA (1939) Influence of massive doses of insulin on peripheral blood flow in man. Am J Physiol 128: 124–132Google Scholar
  2. Acheson K, Jéquier E, Wahren J (1983) Influence of beta-adrenergic blockade on glucose-induced thermogenesis in man. J Clin Invest 72: 981–986PubMedCrossRefGoogle Scholar
  3. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL (1991) Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87: 2246–2252PubMedCrossRefGoogle Scholar
  4. Andersson B, Elam M, Wallin BG, Björntop P, Andersson OK (1991) Effect of energy-restricted diet on sympathetic muscle nerve activity in obese woman. Hypertension 18: 783–789PubMedGoogle Scholar
  5. Andres M, Baltzan MA, Cader G, Zierler KL (1961) Effect of insulin on carbohydrate metabolism and on potassium in the forearm in man. J Clin Invest 41: 108–115CrossRefGoogle Scholar
  6. Baron AD (1993) Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone. Baillieres Clin Endocrinol Metab 7: 961–987PubMedCrossRefGoogle Scholar
  7. Baron AD, Brechtel-Hook G, Johnson A, Hardin D (1993) Skeletal muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension 21: 129–135PubMedGoogle Scholar
  8. Bennet WM, Connacher AA, Scrimgeour CM, Jung JT, Rennie MJ (1990) Euglycemic hyperinsulinemia augments amino acid uptake by human leg tissues during hyperaminoacidemia. Am J Physiol 259: E185 - E194PubMedGoogle Scholar
  9. Berne C, Fagius J, Pollare T, Hjemdahl P (1992) The sympathetic response to euglycaemic hyperinsulinaemia: evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 35: 873–879PubMedCrossRefGoogle Scholar
  10. Bevan RD (1984) Trophic effects of peripheral adrenergic nerves on vascular structure. Hypertension 6 [Suppl III]: 11119–11126Google Scholar
  11. Bonora E, Zavaroni I, Alpi O, Pezzarossa A, Bruschi F, Dall’Aglio E, Guerrra L, Coscelli C, Butturini U (1987) Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects. Diabetologia 30: 719–723PubMedCrossRefGoogle Scholar
  12. Brown MR, Fisher LA (1985) Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems. Fed Proc 44: 243–248PubMedGoogle Scholar
  13. Calver A, Collier J, Vallance P (1992) Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90: 2548–2554PubMedCrossRefGoogle Scholar
  14. Chrisholm DJ, Klassen GA, Dupre J, Pozefski T (1975) Interaction of secretin and insulin on human forearm metabolism. Eur J Clin Invest 5: 487–494Google Scholar
  15. Christin L, O’Connell M, Bogardus C, Danforth E, Ravussin E (1993) Norepinephrine turnover and energy expenditure in Pima Indian and white men. Metabolism 42: 723–729PubMedCrossRefGoogle Scholar
  16. Clayton S, Cross M (1963) The aggregation of blood platelets by catecholamines and by thrombin. J Physiol (Lond) 169: 82 PGoogle Scholar
  17. Daly PA, Landsberg L (1991) Hypertension in obesity and NIDDM. Diabetes Care 14: 240–248PubMedCrossRefGoogle Scholar
  18. Davisson RL, Hogue AM, Johnson AK, Lewis SJ (1993) Sympathetic vasodilator neurons innervating rat hindlimb vasculature may release nitrosyl factors. Hypertension 22: 413Google Scholar
  19. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214 - E223PubMedGoogle Scholar
  20. DiSalvo RJ, Bloom WL, Brust AA, Ferguson RW, Ferris EB (1956) A comparison of the metabolic and circulatory effects of epinephrine, norepinephrine and insulin hypoglycemia with observations on the influence of autonomic blocking agents. J Clin Invest 35: 568–577PubMedCrossRefGoogle Scholar
  21. Dustan HP (1991) Obesity and hypertension. Diabetes Care 14: 488–504PubMedCrossRefGoogle Scholar
  22. Felber JP, Haesler E, Jéquier E (1993) Metabolic origin of insulin resistance in obesity with and without Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 1221–1229PubMedCrossRefGoogle Scholar
  23. Ferrannini E, Buzzigogli RD, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilaqua S (1987) Insulin resistance in essential hypertension. N Engi J Med 317: 350–357CrossRefGoogle Scholar
  24. Ferrannini E, Taddei S, Santoro D, Natali A, Boni C, Del Chiaro D, Buzzigoli G (1988) Independent stimulation of glucose metabolism and Na-K exchange by insulin in the human forearm. Am J Physiol 255: E953 - E958PubMedGoogle Scholar
  25. Gelfand RA, Barret EJ (1987) Effect of physiological hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J Clin Invest 8o: 1–6CrossRefGoogle Scholar
  26. Ginsburg J, Paton A (1956) Effects of insulin after adrenalectomy. Lancet 271: 491–494PubMedCrossRefGoogle Scholar
  27. Gordon T, Kannel WB (1976) Obesity and cardiovascular disease: the Framingham study. Clin Endocrinol Metab 5: 367–375PubMedCrossRefGoogle Scholar
  28. Gosink PD, Chauvez M, Green PK, Woods SC, Figlewicz DP, Wilkinson CW, Baskin DG, Schwartz MW (1992) Central insulin administration lowers body weight via a glucocorticoid sensitive mechanism. Clin Res 40: 55AGoogle Scholar
  29. Gruber KA, Callahan MF (1989) ACTH-(4-lo) through gamma-MSH: evidence for a new class of central autonomic system-regulating peptides. Am J Physiol 257: R681 - R694PubMedGoogle Scholar
  30. Hohnloser J, Von Werder K, Müller OA (1989) Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone. Clin Endocrinol (Oxf) 31: 175–184CrossRefGoogle Scholar
  31. Holt S, York DA, Fitzsimons JTR (1983) The effect of corticosterone, cold exposure and overfeeding with sucrose on brown adipose tissue of obese Zucker rats (fa/fa). Biochem J 214: 215–223PubMedGoogle Scholar
  32. Hwang IS, Ho H, Hoffman BB, Reaven GM (1987) Fructose-induced insulin resistance and hypertension in rats. Hypertension 14: 117–119Google Scholar
  33. Jacobs DB, Sowers JR, Hmeidan A, Niyogi T, Simpson L, Standley PR (1993) Effects of weight reduction on cellular cation metabolism and vascular resistance. Hypertension 21: 308–314PubMedGoogle Scholar
  34. Kurosawa M, Sato A, Swenson R, Takahashi Y (1985) Sympatho-adrenal medullary functions in response to intracerebroventricular injected corticotropin-releasing factor in anesthetized rats. Brain Res 367: 250–257CrossRefGoogle Scholar
  35. Laakso M, Edelman SV, Brechtel G, Baron AD (1990a) Decreased effect of insulin to stimulate muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 85: 1844–1852PubMedCrossRefGoogle Scholar
  36. Laakso M, Edelman SV, Olefsky JM, Brechtel G, Wallace P, Baron AD (1990b) Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes 39: 965–974PubMedCrossRefGoogle Scholar
  37. Laakso M, Edelman SV, Brechtel G, Baron AD (1992a) Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 41: 1076–1083PubMedCrossRefGoogle Scholar
  38. Laakso M, Edelman SV, Brechtel G, Baron AD (1992b) Effects of epinephrine on insulin-mediated glucose uptake in whole body and leg muscle in humans: role of blood flow. Am J Physiol 263: E199 - E204PubMedGoogle Scholar
  39. Landsberg L (1986) Diet, obesity and hypertension: a hypothesis involving insulin, the sympathetic nervous system and adaptive thermogenesis. Q J Med 236: 1081–1090Google Scholar
  40. Lembo G, Napoli R, Capaldo B, Rendina V, Iaccarino G, Volpe M, Trimarco B, Sacca L (1992) Abnormal sympathetic overactivity evoked by insulin in skeletal muscle of patients with essential hypertension. J Clin Invest 90: 24–29PubMedCrossRefGoogle Scholar
  41. Levy RL, White PD, Stroud WD, Hillman CC (1946) Overweight: prognostic significance in relation to hypertension and cardiovascular disease. JAMA 131: 951–953Google Scholar
  42. Liang C-S, Doherty JU, Faillace R, Maekawa K, Arnold S, Gavras H, Hood WB (1982) Insulin infusion in conscious dogs: effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest 69: 1321–1336PubMedCrossRefGoogle Scholar
  43. Lillioja S, Young AA, Cuiter CL, Ivy JL, Abbot WGH, Zawadski JK, Yki-Järvinen H, Christin L, Secomb TW, Bogardus C (1987) Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987: 415–425CrossRefGoogle Scholar
  44. Lucas CP, Estigarribia JA, Darga LL, Reaven GM (1985) Insulin and blood pressure in obesity. Hypertension 7: 702–706PubMedGoogle Scholar
  45. Margolis RU, Altszuler N (1967) Insulin in the cerebrovascular fluid. Nature 215: 1375–1376PubMedCrossRefGoogle Scholar
  46. Modan M, Halkin H (1991) Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension. Diabetes Care 14: 470–487PubMedCrossRefGoogle Scholar
  47. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z (1985) Hyperinsulinemia. A link between hypertension, obesity, and glucose intolerance. J Clin Invest 75: 809–817PubMedCrossRefGoogle Scholar
  48. Morgan DA, Balon TW, Mark AL (1991) High fructose diet promotes exaggerated sympathetic and pressor responses to hyperinsulinemia in rats. FASEB J 5: A1497Google Scholar
  49. Morgan DA, Balon TW, Ginsberg BH, Mark AL (1993) Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats. Am J Physiol 264: R423 - R427PubMedGoogle Scholar
  50. Muller JE, Tofler GH, Stone PH (1989) Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 80: 267–275CrossRefGoogle Scholar
  51. Natali A, Buzzigoli G, Taddei S, Santoro D, Cerri M, Pedrinelli R, Ferrannini E (1990) Effects of insulin on hemodynamics and metabolism in the human forearm. Diabetes 39: 490–500PubMedCrossRefGoogle Scholar
  52. Overton JM, Fischer LA (1989) Central nervous system actions of corticotropin-releasing factor on cardiovascular function in the absence of locomotor activity. Regul Pept 25: 315–324PubMedCrossRefGoogle Scholar
  53. Pereda SA, Eckstein JW, Abboud FM (1962) Cardiovascular responses to insulin in the absence of hypoglycemia. Am J Physiol 202: 249–252Google Scholar
  54. Randin D, Vollenweider P, Tappy L, Jéquier E, Nicod P, Scherrer U (1994) Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans. Am J Physiol 266: R809 - R816PubMedGoogle Scholar
  55. Randin D, Vollenweider P, Tappy L, Jéquier E, Nicod P, Scherrer U (1995) Suppression of alcohol-induced sympathetic activation and elevation of arterial pressure by dexamethasone. N Engl J Med 332 (in press)Google Scholar
  56. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle: its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet 1: 785–789PubMedCrossRefGoogle Scholar
  57. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607PubMedCrossRefGoogle Scholar
  58. Richter EA, Mikines KJ, Galbo H, Kiens B (1989) Effect of exercise on insulin action in human skeletal muscle. J Appl Physiol 66: 876–885PubMedGoogle Scholar
  59. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallota J, Landsberg L (1981) Effects of insulin and glu- cose infusions on sympathetic nervous system activity in normal man. Diabetes 30: 219–225PubMedGoogle Scholar
  60. Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA (1989) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320: 1025–1030PubMedCrossRefGoogle Scholar
  61. Sauter A, Goldstein M, Engel J, Ueta K (1983) Effect of insulin on central catecholamines. Brain Res 260: 330–333PubMedCrossRefGoogle Scholar
  62. Scherrer U, Vissing SF, Morgan BJ, Rollins JA, Tindall RSA, Ring S, Hanson P, Mohanty PK, Victor RG (1990) Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 323: 693–699PubMedCrossRefGoogle Scholar
  63. Scherrer U, Vollenweider P, Randin D, Jéquier E, Nicod P, Tappy L (1993) Suppression of insulin induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation 88: 388–394PubMedGoogle Scholar
  64. Scherrer U, Randin D, Tappy L, Vollenweider P, Jéquier E, Nicod P (1994a) Body fat and sympathetic nerve activity in healthy subjects. Circulation 89: 2634–2640PubMedGoogle Scholar
  65. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P (1994b) Nitric oxide release accounts for insulin’s vascular effects in humans. J Clin Invest 94: 2511–2515PubMedCrossRefGoogle Scholar
  66. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte DJ (1992) Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 13: 387–414PubMedGoogle Scholar
  67. Scott NA, Webb V, Boublik JH, Rivier J, Brown MR (1989) The cardiovascular actions of centrally administered neuropeptide Y. Regul Pept 25: 247–258PubMedCrossRefGoogle Scholar
  68. Shen DC, Shieh SM, Fuh MT, Wu DA, Chen YDI, Reaven GM (1988) Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 66: 580–583PubMedCrossRefGoogle Scholar
  69. Shepherd JT (1990) Increased systemic vascular resistance and primary hypertension: the expanding complexity. J Hypertens 8 [Suppl 7]: 515–527Google Scholar
  70. Shepherd JT, Vanhoutte PM (1979) Interactions between cardiovascular and endocrine control. In: Shepherd JT, Vanhoutte PM (eds) The human cardiovascular system. Facts and concepts. Raven, New York, p 153Google Scholar
  71. Sloan JA, Hooper M, Izzo JL Jr (1989) Effects of circulating norepinephrine on platelets, leukocyte and RBC counts by alphas-adrenergic stimulation. Am J Cardiol 63: 1140–1142CrossRefGoogle Scholar
  72. Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA (1993) Reduced sympathetic nerve activity. A potential mechanism predisposing to body weight gain. J Clin Invest 92: 1730–1735PubMedCrossRefGoogle Scholar
  73. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD (1994) Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94: 1172–1179PubMedCrossRefGoogle Scholar
  74. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Hirooka Y, Ando S, Takeshita A (1993) Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels. J Clin Invest 92: 1483–1490PubMedCrossRefGoogle Scholar
  75. Takeshita AT, Mark AL (1980) Decreased vasodilator capacity of forearm resistance vessels in borderline hypertension. Hypertension 2: 610–616PubMedGoogle Scholar
  76. Valiance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet ii: 997–1000CrossRefGoogle Scholar
  77. Vallbo AB, Hagbarth KE, Torebjörk HE, Wallin BG (1979) Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 59: 919–957PubMedGoogle Scholar
  78. Van Houten M, Posner BI (1979) Insulin binds to brain blood vessels. Nature 282: 623–625PubMedCrossRefGoogle Scholar
  79. Victor RG, Leimbach WN, Seals DR, Wallin BG, Mark AL (1987) Effects of the cold pressure test on muscle sympathetic nerve activity in humans. Hypertension 9: 429–436PubMedGoogle Scholar
  80. Vollenweider P, Tappy L, Randin D, Schneiter P, Jéquier E, Nicod P, Scherrer U (1993) Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 92: 147–154PubMedCrossRefGoogle Scholar
  81. Vollenweider P, Randin D, Tappy L, Jéquier E, Nicod P, Scherrer U (1994) Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 93: 2365–2371PubMedCrossRefGoogle Scholar
  82. Vollenweider L, Tappy L, Owlya R, Jéquier E, Nicod P, Scherrer U (1995) Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes 44 (in press)Google Scholar
  83. Yang YI, Hope ID, Ader M, Bergman RN (1989) Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 84: 1620–1628PubMedCrossRefGoogle Scholar
  84. Young JB, Landsberg L (1977) Stimulation of the sympathetic nervous system during sucrose feeding. Nature 269: 615–617PubMedCrossRefGoogle Scholar
  85. Young JB, Saville E, Rothwell NJ, Stock MJ, Landsberg L (1982) Effect of diet and cold exposure on norepinephrine turnover in brown adipose tissue in the rat. J Clin Invest 69: 1061–1071PubMedCrossRefGoogle Scholar
  86. Young JB, Macdonald IA (1992) Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes 16: 959–967Google Scholar
  87. Zurlo F, Larson K, Bogardus C, Ravussin E (1990) Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 86: 1423–1427PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • U. Scherrer

There are no affiliations available

Personalised recommendations